Charles River Laboratories (CRL) Tops Q1 EPS by 25c; raises guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $280.05 --0%
Financial Fact:
Net sales related to products: 132.87M
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Net sales related to products: 132.87M
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.34, $0.25 better than the analyst estimate of $2.09. Revenue for the quarter came in at $984.2 million versus the consensus estimate of $941.47 million.
GUIDANCE:
Charles River Laboratories sees FY2025 EPS of $9.30-$9.80, versus the consensus of $9.31.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
